ProfoundBio has raised $ 70 million promote two of their oncology drug candidates in clinical trials. The company evolving antibody conjugates are drugs that target cells with antibodies and deliver toxins. This is the same class of drugs sold by biotech giant Seattle Siegen, the previous employer of the CEO of the co-founders of Profound. Baiten ZhaoCOO Tae Khan and technical director Xiao Shang. Sequoia of China tops $ 55 million Series A + Round Series A last summer for Chinese startups Woodinville, Washington, and Suzhou. CEO of Sequoia Capital Lin Yang will be a member of the company’s board of directors.
Related Posts
University reprimands professor whose tweet about dying queen prompts response from Jeff Bezos – GeekWire
Professor Uju Anya, left, and Jeff Bezos. (Photo via Twitter, Amazon)A professor whose tweet about…
Math can help solve forensic genetic cases 10 times faster
Researchers have a new strategy that could speed up cold case investigations.Solving crimes through forensic…
More than 40 technologists will work in the first American Digital Corps
List of cookies A cookie is a small piece of data (a text file) that…